Cano Health, Inc.
CANOQ
OTC PK
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 2.96B | 3.14B | 3.10B | 2.98B | 2.90B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.96B | 3.14B | 3.10B | 2.98B | 2.90B |
| Cost of Revenue | 2.97B | 3.06B | 2.95B | 2.73B | 2.50B |
| Gross Profit | -13.30M | 79.28M | 153.12M | 249.11M | 404.16M |
| SG&A Expenses | 349.85M | 357.21M | 384.54M | 415.48M | 422.24M |
| Depreciation & Amortization | 97.23M | 106.08M | 107.64M | 106.24M | 98.83M |
| Other Operating Expenses | 62.00M | 62.00M | 62.00M | 62.00M | -- |
| Total Operating Expenses | 3.48B | 3.58B | 3.50B | 3.31B | 3.02B |
| Operating Income | -522.38M | -446.01M | -401.06M | -334.61M | -116.91M |
| Income Before Tax | -1.52B | -1.10B | -1.13B | -746.67M | -487.81M |
| Income Tax Expenses | -1.78M | -1.82M | -501.00K | -1.60M | 1.08M |
| Earnings from Continuing Operations | -1.52K | -1.10K | -1.12K | -745.07 | -488.89 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 534.55M | 504.49M | 547.00M | 373.57M | 252.81M |
| Net Income | -981.97M | -594.42M | -577.76M | -371.50M | -236.08M |
| EBIT | -522.38M | -446.01M | -401.06M | -334.61M | -116.91M |
| EBITDA | -425.15M | -339.93M | -293.42M | -228.37M | -18.09M |
| EPS Basic | -288.02 | -209.29 | -216.13 | -147.59 | -98.88 |
| Normalized Basic EPS | 4.86 | 55.42 | 112.14 | 52.36 | 68.11 |
| EPS Diluted | -300.34 | -221.27 | -216.46 | -147.93 | -99.71 |
| Normalized Diluted EPS | 18.59 | 63.14 | 119.86 | 60.08 | 68.24 |
| Average Basic Shares Outstanding | 13.21M | 11.01M | 10.40M | 9.89M | 9.24M |
| Average Diluted Shares Outstanding | 16.39M | 16.18M | 15.57M | 15.06M | 14.53M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
